|
RAB10 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.482400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.813800E-01 |
| Normal-vs-Stage2 |
1.250780E-01 |
| Normal-vs-Stage3 |
3.588000E-02 |
| Normal-vs-Stage4 |
1.936790E-01 |
| Stage1-vs-Stage2 |
1.245250E-01 |
| Stage1-vs-Stage3 |
1.110350E-02 |
| Stage1-vs-Stage4 |
8.650300E-02 |
| Stage2-vs-Stage3 |
5.135000E-01 |
| Stage2-vs-Stage4 |
5.605000E-01 |
| Stage3-vs-Stage4 |
9.716600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.394600E-01 |
| Normal-vs-AfricanAmerican |
5.628200E-01 |
| Normal-vs-Asian |
2.882600E-01 |
| Caucasian-vs-AfricanAmerican |
9.077600E-01 |
| Caucasian-vs-Asian |
2.945800E-01 |
| AfricanAmerican-vs-Asian |
2.659600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.904400E-01 |
| Normal-vs-Female |
2.500100E-03 |
| Male-vs-Female |
5.634200E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.553000E-01 |
| Normal-vs-Extreme_Weight |
5.484400E-02 |
| Normal-vs-Obese |
1.549410E-01 |
| Normal-vs-Extreme_Obese |
5.426600E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.117850E-01 |
| Normal_Weight-vs-Obese |
4.370800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.816200E-01 |
| Extreme_Weight-vs-Obese |
1.475880E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.558400E-01 |
| Obese-vs-Extreme_Obese |
9.276600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.854400E-02 |
| Normal-vs-Age(41-60Yrs) |
1.173960E-01 |
| Normal-vs-Age(61-80Yrs) |
8.888600E-01 |
| Normal-vs-Age(81-100Yrs) |
1.185170E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.386000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.100500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.922230E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.686650E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.145850E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.726200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.808600E-01 |
| Normal-VS-Type2 PRCC |
5.047400E-01 |
| Normal-VS-KIRP CIMP |
4.559300E-03 |
| Normal-VS-Unclassified PRCC |
1.429180E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.160200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.71915999999106E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
1.163220E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.182100E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
5.346200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.401500E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.247200E-01 |
| Normal-vs-N1 |
7.896500E-03 |
| Normal-vs-N2 |
6.142600E-01 |
| N0-vs-N1 |
4.479000E-03 |
| N0-vs-N2 |
3.576800E-01 |
| N1-vs-N2 |
4.164400E-01 |
|
|
